Table 3.
Category | Number of Classes | Majority Class | Frequency Range (Mean ± Std Dev) | Number of Unseen Classes in Eval. | ||
---|---|---|---|---|---|---|
| ||||||
Dev./Eval. | Dev. | Eval. | Dev. | Eval. | ||
Basis of Diagnosis | 3 | 08 | 08 | 19–146 (67±69) | 21–175 (73±88) | – |
Histological Type | 64/94 | M-81403 | M-81403 | 1–35 (3.1±5.4) | 1–21 (2.3±3.1) | 65 (69%) |
Histological Grade | 7 | 9 | 9 | 3–110 (28.7±38.1) | 1–129 (31.4±44.6) | – |
Primary Site | 58/66 | C50.9 | C42.1 | 1–21 (3.4±4.1) | 1–39 (3.3±5.9) | 30 (45%) |
Laterality | 4/5 | 8 | 8 | 20–129 (50.3±52.6) | 1–134 (44.0±52.4) | 1 (20%) |
Metastatic Site | 17/19 | NA | NA | 1–170 (11.2±39.7) | 1–192 (11.0±42.6) | 10 (53%) |
Metastatic Status | 2 | NA | NA | 31–170 (101±98) | 28–192 (110±116) | – |
Dev., development set (N=201); Eval., evaluation set (N=220); Std Dev, standard deviation; NA, ‘Not Applicable’ class